ACD/Labs Launches Version 2024 of Spectrus Software for Digitalized, Data-Driven R&D

ACD/Labs, an informatics company that develops and commercializes software in support of digitalized R&D, today announced the release of version 2024 of Spectrus Platform applications.

Supporting digital transformation projects and enabling organizations to leverage their R&D data in AI/ML applications continue to be an important focus for ACD/Labs. “Digitalization is the key to unlocking the value of data in R&D,” says Andrew Anderson, Vice President of Innovation and Informatics Strategy at ACD/Labs. “Life sciences organizations have made strides in breaking down data silos and digitalizing processes, but the variety of instrumentation, systems, and workflows makes it challenging. And while vast amounts of data are generated, normalization and context for secondary use by data scientists and machines is a relatively new problem in many labs. We will continue to support our customers and anticipate their needs through the development and modernization of our software stack.”

ACD/Labs’ offerings for pharmaceutical process development, chemistry manufacturing and control (CMC), and high throughput experimentation (HTE) have replaced unsophisticated technologies (e.g., spreadsheets) and complex workarounds. Enhancements to Luminata® and Katalyst D2D® software include support for accelerated stability studies used in the determination of shelf life and drug expiry; improved integration with third-party software systems to eliminate busy work and ensure data integrity; and the introduction of integrated AI tools to help lab scientists make use of these technologies.

For more than a decade, software in the Spectrus portfolio has presented scientists with processed, assembled data from all major instrument vendors and analytical techniques. Used by researchers for structure elucidation and verification; to monitor processes in development and manufacturing; for quality control; to identify, isolate, and quantify compounds; and more, these tools have seen enhancements to benefit productivity and decision-making in R&D. Version 2024 delivers improvements to qualitative and quantitative analysis by NMR and MS and in the visualization of analytical data. Collaboration between researchers will be more streamlined through better data management and access, and more efficient automated structure verification (ASV) will increase lab productivity.

ACD/Labs is continuing to develop its suite of browser-based tools for analytical data handling, with significant expansion to the functionality and capabilities of both Spectrus Processor JS and Spectrus Manager JS.

For more information on v2024 updates to Spectrus software, visit acdlabs.com/whatsnew.

About ACD/Labs
ACD/Labs is a leading provider of scientific software, aiding decision-making and digital transformation in chemical and pharmaceutical R&D.

Our science-centric solutions offer harmonized, AI-ready analytical, structural, and molecular information, with FAIR-compliance. Our cloud-enabled technologies enable the proliferation of chemically intelligent knowledge and workflow automation.

For 30 years, we have partnered with global organizations to enhance productivity and accelerate scientific innovation. For more information, please visit www.acdlabs.com. Follow us on X (Twitter) and LinkedIn.

Contact Information

Jessica Walter

Junior Account Executive

The Scott Partnership

(44) 1477 539 539

tspacd@scottpr.com